金城医药 (300233.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(金城医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2020年三季报2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报
主要指标:
 营业收入(元) 1,936,858,726.931,273,354,991.10650,685,404.332,794,819,332.701,964,362,438.541,281,977,257.53634,385,558.13
 营业利润(元) 263,991,177.40209,861,386.02123,061,070.78155,327,555.14371,832,951.81264,213,401.79116,003,166.55
 利润总额(元) 258,818,616.57205,526,588.37120,290,804.99315,159,059.44533,185,880.88401,012,488.60116,370,495.72
 净利润(元) 212,645,545.78172,780,722.76101,584,922.00214,009,704.05443,798,316.63332,971,470.2999,237,563.89
 归属于母公司股东的净利润(元) 207,683,729.50169,143,389.02101,030,988.13203,285,186.73434,902,726.40325,245,253.2898,071,895.99
盈利能力:
 销售毛利率(%) 58.8756.0052.2758.4758.3459.1455.65
 销售净利率(%) 10.9813.5715.617.6622.5925.9715.64
 净资产收益率(%) 4.944.042.45----
 总资产报酬率ROA(%) 4.893.772.17----
 投入资本回报率ROIC(%) 4.343.572.134.409.347.002.09
营运能力:
 存货周转率(次) 2.611.771.14----
 应收账款周转率(次) 3.632.110.96----
 总资产周转率(次) 0.350.230.12----
偿债能力:
 资产负债率(%) 26.1324.9225.7626.9621.9221.5421.32
 股东权益比率(%) 73.4274.6473.8672.6777.7477.4777.18
 已获利息倍数(倍) 19.92103.98-66.5752.18-526.6085.8416.14
 流动比率 2.301.981.971.862.152.172.24
 速动比率 1.901.621.691.591.711.791.84
发展能力:
 营业收入增长率(%) -1.40-0.672.57-7.09-9.18-15.08-23.34
 营业利润增长率(%) -29.00-20.576.08-57.7822.7838.0129.62
 税后利润增长率(%) -52.25-48.003.02-22.9685.06113.8535.43
 净资产增长率(%) -2.80-2.510.791.366.647.594.35
 总资产增长率(%) 2.921.185.325.787.459.786.11

前瞻产业研究院